FDA Summary Review SYNTHON PHARMS NDA 022026

Summary Review

NDA 022026

SYNTHON PHARMS

Application #022026

Documents

Summary Review2009-02-02

Application Sponsors

NDA 022026SYNTHON PHARMS
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.